Related Experiment Videos
Bioactivity of gonadotropins.
1Department of Pediatrics, University of Michigan Medical School, Ann Arbor.
Endocrinology and Metabolism Clinics of North America
|March 1, 1991
Summary
Gonadotropins like luteinizing hormone (LH) and follicle-stimulating hormone (FSH) exist as diverse isoforms with varying bioactivity. Measuring bioactivity, not just immunoreactivity, offers deeper insights into their function, particularly during human puberty.
Area of Science:
- Endocrinology
- Reproductive Biology
- Molecular Endocrinology
Background:
- Gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), are crucial for reproductive function.
- These hormones circulate as heterogeneous isoforms with distinct bioactive to immunoreactive potentials.
- Understanding isoform variations is key to comprehending reproductive development.
Purpose of the Study:
- To differentiate the roles of bioactive versus immunoreactive gonadotropin isoforms.
- To highlight the significance of bioactivity measurements in understanding human puberty.
- To review methodological advances in gonadotropin isoform analysis.
Main Methods:
- In vitro bioactivity assays defining LH's T production and FSH's E2 production.
- Measurement of immunologic potencies using specific antibodies.
- Comparison of bioactivity and immunoreactivity results, especially for FSH.
Main Results:
- Bioactivity measurements revealed greater functional excursions than immunologic potencies, particularly for FSH.
- Gonadotropin isoforms stimulate postreceptor binding functions, influencing G-protein activation.
- Current isoform separation methods lack the precision to distinguish all functional variants.
Conclusions:
- Bioactivity measurements provide a more comprehensive assessment of gonadotropin function than immunoreactivity alone.
- Understanding gonadotropin isoform heterogeneity is vital for studying human puberty.
- Methodological advancements in bioactivity assays enhance our comprehension of reproductive endocrinology.